These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 24135322
1. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
2. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
3. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study. Mani V, Woodward M, Samber D, Bucerius J, Tawakol A, Kallend D, Rudd JH, Abt M, Fayad ZA. Int J Cardiovasc Imaging; 2014 Mar; 30(3):571-82. PubMed ID: 24458953 [Abstract] [Full Text] [Related]
4. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
5. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, Burgess T, Fuster V, Rudd JH, Tawakol A, Farkouh ME. Am Heart J; 2011 Aug; 162(2):214-221.e2. PubMed ID: 21835280 [Abstract] [Full Text] [Related]
6. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study. Kang MK, Kim CJ, Choo EH, Han EJ, Hwang BH, Kim JJ, Kim SH, O JH, Chang K. Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997 [Abstract] [Full Text] [Related]
7. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T. JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871 [Abstract] [Full Text] [Related]
8. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J. JACC Cardiovasc Imaging; 2012 Sep; 5(9):911-22. PubMed ID: 22974804 [Abstract] [Full Text] [Related]
9. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial. Boczar KE, Shin S, deKemp RA, Dowlatshahi D, Tavoosi A, Wiefels C, Liu P, Lochnan H, MacPherson PA, Chong AY, Torres C, Leung E, Tawakol A, Ahmadi A, Garrard L, Lefebvre C, Kelly C, MacPhee P, Tilokee E, Raggi P, Wells GA, Beanlands R. BMJ Open; 2023 Nov 10; 13(11):e074463. PubMed ID: 37949621 [Abstract] [Full Text] [Related]
10. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A, dal-PLAQUE Investigators. Lancet; 2011 Oct 29; 378(9802):1547-59. PubMed ID: 21908036 [Abstract] [Full Text] [Related]
11. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Calcagno C, Ramachandran S, Izquierdo-Garcia D, Mani V, Millon A, Rosenbaum D, Tawakol A, Woodward M, Bucerius J, Moshier E, Godbold J, Kallend D, Farkouh ME, Fuster V, Rudd JH, Fayad ZA. Eur J Nucl Med Mol Imaging; 2013 Dec 29; 40(12):1884-93. PubMed ID: 23942908 [Abstract] [Full Text] [Related]
12. Carotid Plaque Inflammation Assessed by 18F-FDG PET/CT and Lp-PLA2 Is Higher in Symptomatic Patients. Bueno A, March JR, Garcia P, Cañibano C, Ferruelo A, Fernandez-Casado JL. Angiology; 2021 Mar 29; 72(3):260-267. PubMed ID: 33089697 [Abstract] [Full Text] [Related]
13. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
14. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN. Acad Radiol; 2015 May 03; 22(5):600-9. PubMed ID: 25708866 [Abstract] [Full Text] [Related]
15. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation. Oh M, Kim H, Shin EW, Sung C, Kim DH, Moon DH, Lee CW. BMC Cardiovasc Disord; 2019 Aug 19; 19(1):201. PubMed ID: 31426749 [Abstract] [Full Text] [Related]
16. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. Myers KS, Rudd JH, Hailman EP, Bolognese JA, Burke J, Pinto CA, Klimas M, Hargreaves R, Dansky HM, Fayad ZA. JACC Cardiovasc Imaging; 2012 Jan 19; 5(1):38-45. PubMed ID: 22239891 [Abstract] [Full Text] [Related]
17. Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation. Oh M, Lee CW, Lee HS, Chang M, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Moon DH, Park SW, Park SJ. Clin Cardiol; 2016 Nov 19; 39(11):646-652. PubMed ID: 27459273 [Abstract] [Full Text] [Related]
18. Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging: Implications for Vascular Interventional Studies. van der Valk FM, Verweij SL, Zwinderman KA, Strang AC, Kaiser Y, Marquering HA, Nederveen AJ, Stroes ES, Verberne HJ, Rudd JH. JACC Cardiovasc Imaging; 2016 Oct 19; 9(10):1198-1207. PubMed ID: 27639759 [Abstract] [Full Text] [Related]
19. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA. Circ Cardiovasc Imaging; 2009 Mar 19; 2(2):107-15. PubMed ID: 19808576 [Abstract] [Full Text] [Related]
20. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Saito H, Kuroda S, Hirata K, Magota K, Shiga T, Tamaki N, Yoshida D, Terae S, Nakayama N, Houkin K. Cerebrovasc Dis; 2013 Mar 19; 35(4):370-7. PubMed ID: 23635390 [Abstract] [Full Text] [Related] Page: [Next] [New Search]